446
Views
19
CrossRef citations to date
0
Altmetric
Original Articles

Perfluoroalkyl acids (PFAAs) and anthropometric measures in the first year of life: Results from the Duisburg Birth Cohort

, , , &

References

  • Andersen, C. S., Fei, C., Gamborg, M., Nohr, E. A., Sørensen, T. I. A., and Olsen, J. 2010. Prenatal exposures to perfluorinated chemicals and anthropometric measures in infancy. Am. J. Epidemiol. 17: 1230–1237.
  • Andersen, C. S., Fei, C., Gamborg, M., Nohr, E. A., Sørensen, T. I. A., and Olsen, J. 2013. Prenatal exposures to perfluorinated chemicals and anthropometry at 7 years of age. Am. J. Epidemiol. 178: 921–927.
  • Apelberg, B. J., Witter, F. R., Herbstman, J. B., Calafat, A. M., Halden, R. U., Needham, L. L., and Goldman, L. R. 2007. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ. Health Perspect. 115: 1670–1676.
  • Bach, C. C., Bech, B. H., Brix, N., Nohr, E. A., Bonde, J. P., and Henriksen, T. B. 2015. Perfluoroalkyl and polyfluoroalkyl substances and human fetal growth: A systematic review. Crit. Rev. Toxicol. 45: 53–67.
  • Cao, Y., Winneke, G., Wilhelm, M., Wittsiepe, J., Lemm, F., Fürst, P., Ranft, U., Imöhl, M., Kraft, M., Oesch-Bartlomowicz, B., and Krämer, U. 2008. Environmental exposure to dioxins and polychlorinated biphenyls reduce levels of gonadal hormones in newborns: Results from the Duisburg cohort study. Int. J. Hyg. Environ. Health 211: 30–39.
  • Chen, M.-H., Ha, E.-H., Wen, T.-W., Su, Y.-N., Lien, G.-W., Chen, C.-Y., Chen, P.-C., and Hsieh, W.-S. 2012. Perfluorinated compounds in umbilical cord blood and adverse birth outcomes. PLoS ONE 77: e42474.
  • Darrow, L. A., Stein, C. R., and Steenland, K. 2013. Serum perfluorooctanoic acid and perfluorooctane sulfonate concentrations in relation to birth outcomes in the Mid-Ohio Valley, 2005–2010. Environ. Health Perspect. 121: 1207–1213.
  • Ehresman, D. J., Froehlich, J. W., Olsen, G. W., Chang, S.-C., and Butenhoff, J. L. 2007. Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals. Environ. Res. 103: 176–184.
  • Fei, C., McLaughlin, J. K., Tarone, R. E., and Olsen, J. 2007. Perfluorinated chemicals and fetal growth: A study within the Danish National Birth Cohort. Environ. Health Perspect. 115: 1677–1682.
  • Fromme, H., Mosch, C., Morovitz, M., Alba-Alejandre, I., Boehmer, S., Kiranoglu, M., Faber, F., Hannibal, I., Genzel-Boroviczény, O., Koletzko, B., and Völkel, W. 2010. Pre- and postnatal exposure to perfluorinated compounds (PFCs). Environ. Sci. Technol. 44: 7123–7129.
  • Fromme, H., Tittlemier, S. A., Völkel, W., Wilhelm, M., and Twardella, D. 2009. Perfluorinated compounds—Exposure assessment for the general population in western countries. Int. J. Hyg. Environ. Health 212: 239–270.
  • Grice, M. M., Alexander, B. H., Hoffbeck, R., and Kampa, D. M. 2007. Self-reported medical conditions in perfluorooctanesulfonyl fluoride manufacturing workers. J. Occup. Environ. Med. 49: 722–729.
  • Halldorsson, T. I., Rytter, D., Haug, L. S., Bech, B. H., Danielsen, I., Becher, G., Henriksen, T. B., and Olsen, S. F. 2012. Prenatal exposure to perfluorooctanoate and risk of overweight at 20 years of age: A prospective cohort study. Environ. Health Perspect. 120: 668–673.
  • Hamm, M. P., Cherry, N. M., Chan, E., Martin, J. W., and Burstyn, I. 2010. Maternal exposure to perfluorinated acids and fetal growth. J. Expos. Sci. Environ. Epidemiol. 20: 589–597.
  • Hanssen, L., Röllin, H., Odland, J. Ø., Moe, M. K., and Sandanger, T. M. 2010. Perfluorinated compounds in maternal serum and cord blood from selected areas of South Africa: Results of a pilot study. J. Environ. Monit. 12: 1355–1361.
  • Hines, E. P., White, S. S., Stanko, J. P., Gibbs-Flournoy, E. A., Lau, C., and Fenton, S. E. 2009. Phenotypic dichotomy following developmental exposure to perfluorooctanoic acid (PFOA) in female CD-1 mice: Low doses induce elevated serum leptin and insulin, and overweight in mid-life. Mol. Cell. Endocrinol. 304: 97–105.
  • Inoue, K., Okada, F., Ito, R., Kato, S., Sasaki, S., Nakajima, S., Uno, A., Saijo, Y., Sata, F., Yoshimura, Y., Kishi, R., and Nakazawa, H. 2004. Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: Assessment of PFOS exposure in a susceptible population during pregnancy. Environ. Health Perspect. 112: 1204–1207.
  • Jiang, Q., Lust, R. M. and DeWitt, J. C. 2013. Perfluorooctanoic acid induced-developmental cardiotoxicity: Are peroxisome proliferator activated receptor alpha (PPAR alpha) and bone morphorgenic protein 2 (BMP2) pathways involved? J. Toxicol. Environ. Health A 76: 635–650.
  • Johnson, P. I., Sutton, P., Atchley, D. S., Koustas, E., Lam, J., Sen, S., Robinson, K. A., Axelrad, D. A., and Woodruff, T. J. 2014. The Navigation Guide—Evidence-based medicine meets environmental health: Systematic review of human evidence for PFOA effects on fetal growth. Environ. Health Perspect. 122: 1028–1039.
  • Lau, C., Anitole, K., Hodes, C., Lai, D., Pfahles-Hutchens, A., and Seed, J. 2007. Perfluoroalkyl acids: A review of monitoring and toxicological findings. Toxicol. Sci. 99: 366–394.
  • Lau, C., Butenhoff, J. L., and Rogers, J. M. 2004. The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol. Appl. Pharmacol. 198: 231–241.
  • Lee, Y. J., Kim, M.-K., Bae, J., and Yang, J.-H. 2013. Concentrations of perfluoroalkyl compounds in maternal and umbilical cord sera and birth outcomes in Korea. Chemosphere 90: 1603–1609.
  • Maisonet, M., Terrell, M. L., McGeehin, M. A., Christensen, K. Y., Holmes, A., Calafat, A. M., and Marcus, M. 2012. Maternal concentrations of polyfluoroalkyl compounds during pregnancy and fetal and postnatal growth in British girls. Environ. Health Perspect. 120: 1–26.
  • Midasch, O., Drexler, H., Hart, N., Beckmann, M. W., and Angerer, J. 2007. Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: A pilot study. Int. Arch. Occup. Environ. Health 80: 643–648.
  • Monroy, R., Morrison, K., Teo, K., Atkinson, S., Kubwabo, C., Stewart, B., and Foster, W. G. 2008. Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples. Environ. Res. 108: 56–62.
  • Morris, S. S., Victoria, C. G., Barros, F. C., Halpern, R., Menezes, A. M. B., César, J. A., Horta, B. L., and Tomasi, E. 1998. Length and ponderal index at birth: Associations with mortality, hospitalizations, development and post-natal growth in Brazilian infants. Int. J. Epidemiol. 27: 242–247.
  • Mosch, C., Kiranoglu, M., Fromme, H., and Völkel, W. 2010. Simultaneous quantitation of perfluoroalkyl acids in human serum and breast milk using on-line sample preparation by HPLC column switching coupled to ESI-MS/MS. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 878: 2652–2658.
  • Needham, L. L., Grandjean, P., Heinzow, B., Jørgensen, P. J., Nielsen, F., Patterson, D. G., Sjödin, A., Turner, W. E., and Weihe, P. 2011. Partition of environmental chemicals between maternal and fetal blood and tissues. Environ. Sci. Technol. 45: 1121–1126.
  • Nolan, L. A., Nolan, J. M., Shofer, F. S., Rodway, N. V., and Emmett, E. A. 2009. The relationship between birth weight, gestational age and perfluorooctanoic acid (PFOA)-contaminated public drinking water. Reprod. Toxicol. 27: 231–238.
  • Olsen, G. W., and Zobel, L. R. 2007. Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers. Int. Arch. Occup. Environ. Health. 81: 231–246.
  • Post, G. B., Cohn, P. D., and Cooper, K. R. 2012. Perfluorooctanoic acid (PFOA), an emerging drinking water contaminant: A critical review of recent literature. Environ. Res. 116: 93–117.
  • Savitz, D. A., Stein, C. R., Bartell, S. M., Elston, B., Gong, J., Shin, H.-M., and Wellenius, G. A. 2012. Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community. Epidemiology 23: 386–392.
  • Schulz, C., Wilhelm, M., Heudorf, U., and Kolossa-Gehring, M. 2012. Reprint of “Update of the reference and HBM values derived by the German Human Biomonitoring Commission.” Int. J. Hyg. Environ. Health 215: 150–158.
  • So, M. K., Yamashita, N., Taniyasu, S., Jiang, Q., Giesy, J. P., Chen, K., and Lam, P. K. S. 2006. Health risks in infants associated with exposure to perfluorinated compounds in human breast milk from Zhoushan, China. Environ. Sci. Technol. 40: 2924–2929.
  • Stein, C. R., Savitz, D. A., and Dougan, M. 2009. Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome. Am. J. Epidemiol. 170: 837–846.
  • Voigt, M., Friese, K., Pawlowski, P., Schneider, R., Wenzlaff, P., and Wermke, K. 2001. Analyse des Neugeborenenkollektivs der Jahre1995–1997 der Bundesrepublik Deutschland–6. Mitteilung: Unterschiedein der Geburtsgewichtsklassifikation in den einzelnen Bundesländernunter Zugrundelegung einer einheitlichen Normwertkurve für Deutschland (unter Berücksichtigung anthropometrischer Merkmale der Mütter). Geburtshilfe Frauenheilkd. 61: 700–706.
  • Washino, N., Saijo, Y., Sasaki, S., Kato, S., Ban, S., Konishi, K., Ito, R., Nakata, A., Iwasaki, Y., Saito, K., Nakazawa, H., and Kishi, R. 2009. Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth. Environ. Health Perspect. 117: 660–667.
  • Whitworth, K. W., Haug, L. S., Baird, D. D., Becher, G., Hoppin, J. A., Skjaerven, R., Thomsen, C., Eggesbo, M., Travlos, G., Wilson, R., Cupul-Uicab, L. A., Brantsaeter, A. L., and Longnecker, M. P. 2012. Perfluorinated compounds in relation to birth weight in the Norwegian mother and child cohort study. Am. J. Epidemiol. 175: 1209–1216.
  • Wilhelm, M., Wittsiepe, J., Lemm, F., Ranft, U., Kramer, U., Furst, P., Roseler, M. Greshake, M. Imohl, G. Eberwein, K., Rauchfuss, M., Kraft, G.,and Winneke, G. 2008. The Duisburg birth cohort study: Influence of the prenatal exposure to PCDD/Fs and dioxin-like PCBs on thyroid hormone status in newborns and neurodevelopment of infants until the age of 24 months. Mutat. Res. 659: 83–92.
  • Wilhelm, M., Wittsiepe, J., Völkel, W., Fromme,H., and Kasper-Sonnenberg, M. 2015. Perfluoroalkyl acids in children and their mothers: Association with drinking water and time trends of inner exposures—Results of the Duisburg birth cohort and Bochum cohort studies. Int. J. Hyg. Environ. Health. 218: 645–655.
  • Wu, K., Xu, X., Peng, L., Liu, J., Guo, Y., and Huo, X. 2012. Association between maternal exposure to perfluorooctanoic acid (PFOA) from electronic waste recycling and neonatal health outcomes. Environ. Int. 48: 1–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.